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 Abstract 
 Collagen hydrogel has been broadly studied and applied in engineering 
3D scaffold materials in tissue engineering. A collagen hydrogel can provide 
cells with a porous and soft environment to proliferate and differentiate. 
However, lacking mechanical stiffness and shrinkage resistance made it a 
challenge to sustain shape and size during a long stem cell differentiation 
process. In addition, a cytocompatible scaffold for human induced 
pluripotent stem cell (iPSC)-laden culture has not been fully investigated. 
The goal of this study is to develop stable and biocompatible collagen-based 
scaffolds that are suitable for direct seeding and lineage progression of 
iPSCs. In this work, three formulas of collagen-based scaffolds were 
developed by fabricating poly(ethylene glycol) diacrylate (PEGDA) into the 
collagen hydrogel to form an interpenetrating network (IPN). Stability test 
showed significant improvement of shrinkage resistance compared to pure 
collagen hydrogel. Assessment of biocompatibility showed high cell 
viability throughout the stem cell differentiation period tested. Quantitative 
real-time polymerase chain reaction (qRT-PCR) analysis indicated the 
scaffolds developed preferentially support iPSCs to differentiate into 
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mesoderm. Taken together, the study has developed collagen-based scaffolds 
that support iPSC seeding, proliferation, and differentiation in 3D cultures. 
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Chapter 1. Introduction and Objectives 
Tissue engineering applied to diabetes treatment 
Diabetes mellitus, also known as diabetes, is a group of disease in which 
high blood sugar level maintains for an abnormal prolonged period. Diabetes 
can cause various compilations including acidosis, kidney dysfunction, heart 
disease, eye damage, coma and even death. 
There are three major types of diabetes: Gestational diabetes, which 
usually occurs in pregnant women; Type 1 diabetes, which is caused by beta 
cell apoptosis directed by multiple cytokines produced by invading immune 
cells.; Type 2 diabetes is caused by beta cell apoptosis induced by chronic 
exposure to elevated levels of glucose and free fatty acids (Cnop et al., 2005, 
Donath et al., 2008). As of 2015, an estimated 415 million people had 
diabetes worldwide, and type 2 diabetes made up about 90% of the cases. 
This represents 8.3% of the adult population, with equal rates in both 
women and men (Y. Shi, et.al., 2014). 
Popular treatment on diabetes, especially type 1 diabetes, includes 
insulin injection and pancreas transplantation. Another promising method is 
building artificial pancreas by means of tissue engineering. To harvest 
functional beta cells that produce insulin, stem cells are an excellent 
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resource to regenerate endocrine cells. They can be seeded into a 3D 
scaffold and cultured in differentiation media containing signaling factors. 
Those signaling factors induce stem cells to differentiate into multiple types 
of somatic cells, and finally develop into a functional artificial pancreas. 
Kroon, E. et al described a four-stage protocol for differentiating human 
embryonic stem cells（hESCs）to pancreatic hormone–expressing 
endocrine cells. Cells at stage 4 of this protocol were similar to fetal 6- to 9-
week pancreatic tissue in that they consist primarily of pancreatic epithelial 
cells, but with few hormone-expressing cells.  
During the four stages stepwise differentiation, hESCs turned into 
endoderm, definitive endoderm (DE), primitive gut tube (PG), posterior 
foregut (PF), and finally pancreatic endoderm (PE). The identification of 
cells is based on the expression level of cell markers showed in Figure 1. 
 There are 3 essential parts in tissue engineering: cell, scaffold and 
signaling molecules. Cells are the major component of desired artificial 
tissue. A scaffold provides an agreeable environment for cells to attach to, 
proliferate and differentiate. A proper 3D scaffold contributes to the 
formation of some specific structures, mimicking microenvironments in the 
body. Signaling factor, including protein molecules and hormones, interacts 
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with receptor of the cells, and eventually manipulate the differentiation 
pathway of pluripotent cells into certain types of cells. 
 
Human induced pluripotent stem cell (iPSCs) in pancreatic tissue 
engineering 
 Three types of human pluripotent stem cells are popular cell sources in 
tissue engineering: human embryotic stem cells (hESCs), umbilical cord 
stem cells, and induced pluripotent stem cells (iPSCs). Embryotic stem cells 
are harvested from the inner cell mass of a blastocyst, so the fetus is 
destroyed during the harvest of hESCs. In that case, the usage of hESCs is 
limited due to the ethical issues. Using umbilical stem cells does not face the 
destruction of a fetus, but to take advantage of this kind of cells, a patient 
needs to preserve the umbilical since birth. It is apparently not feasible for 
all patients. 
 Takahashi and Yamanaka discovered induced pluripotent stem cell 
technology in 2006. The first iPSC line was generated by co-transduction 
with viral vectors expressing 24 different factors, and in further experiments 
they narrowed the required factors down to only four: Oct3/4, Sox 2, Klf4, 
and c-Myc. Oct-4 is a homeodomain transcription factor of the POU family 
and this protein is critically involved in the self-renewal of undifferentiated 
embryonic stem cells by being a marker for undifferentiated cells. Sox2 is a 
4  
  
transcription factor that is essential for maintaining self-renewal of 
undifferentiated embryonic stem cells. As a member of the Sox family, Sox2 
plays a critical role in the maintenance of undifferentiated embryonic and 
neural stem cells and mammalian development. C-Myc is a regulator gene 
that codes a transcription factor, which plays a role in cell cycle progression, 
apoptosis and cellular transformation. KLF4 is a member of KLF family of 
transcription factors and regulates proliferation, differentiation, apoptosis, 
and somatic cell reprogramming. It is also an indicator for stem-like 
capacity. Takahashi et.al. induced adult mouse fibroblast into iPSCs using 
these four factors, and the generated iPSCs showed properties and cell 
morphologies similar with those of embryonic stem cells (Takahashi et al., 
2016). Thus, iPSCs provide a source and has little or no ethical issues, 
making it to be promising materials in pancreatic tissue engineering. 
 By using signaling factors, iPSCs can be induced to functional insulin-
secreting beta cells. For example, Wang et.al. reported a method of inducing 
mouse iPSCs into modified embryoid bodies which are similar to the mouse 
pancreatic beta cell line MIN6 (Wang et.al., 2014). Hoveizi et.al. used 
multiple signaling factors and inducer of definitive endoderm 1 to make 
human iPSCs differentiate into definitive endoderm in a 3D poly(lactic 
acid)/gelatin (PLA/gelatin) nanofibrous scaffold (Hoveizi et.al., 2013).  
5  
  
 
Collagen scaffold 
As mentioned above, a scaffold is another key part in tissue engineering. 
A 3D culture scaffold represents more accurately the actual 
microenvironment where cells reside in tissues. Thus, the behavior of 3D-
cultured cells is more reflective of in vivo cellular responses. In fact, 
research have found that cells in 3D culture environments show different 
morphology and physiology from cells in 2D culture environments. The 3D 
structure of the culture can influence the spatial organization of the cell 
surface receptors engaged in interactions with surrounding cells and induce 
physical constraints to cells. In that way, the signal transduction in 3D 
culture is closer to the real conditions in vivo.  
Collagen is a main structural protein found in connective tissues, such as 
bones, tendons, ligaments and skin. Collagen also exists in other tissues 
including guts, blood vessels and muscles. Fibroblast cells are the most 
common cells that produce collagen in the body. There are 28 types of 
collagen discovered and identified so far. Collagen can be categorized into 
two basic types: fibrillar and non-fibrillar. Among all types of collagen, type 
I collagen, which is over 90% of all collagen, is the most abundant type in 
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human body (Thompson et.al., 2006). Therefore, collagen hydrogels are 
good materials in building 3D scaffolds for tissue engineering. 
As mentioned earlier, compared to 2D culture, a 3D scaffold can provide 
the cells with a differentiation and proliferation environment that is closer to 
in vivo physiological conditions, and thus induce the formation of specific 
somatic cells and the artificial tissue. However, culturing cells in a 3D 
scaffold also has drawback. For example, diffusional transport limitations 
for oxygen and nutrients to the cells may exist.  
 Collagen hydrogel has good histocompatibility, degradability and cell 
recognition signal. Its soft and porous structure allow cells to cluster and 
elongate inside the collagen scaffold. Unlike other extracellular matrix 
products that are harvested in tumor cells such as Matrigel, type I collagen 
extracted from rat tail are better chemical-defined, and has lower possibility 
of inducing tumor formation, especially when using cells with high 
pluripotency such as iPSCs. Collagen hydrogel can also be used as material 
of 3D printing. 3D printing technology can provide scaffolds with more 
defined structure, thus assist stem cells differentiate into target cell types and 
form the tissue. 
 Although collagen hydrogel can provide a good environment for cells to 
spread and elongate inside, it faces shrinkage problems as cells interact with 
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surrounding extracellular matrix. The hydrogel cannot sustain its size and 
structure throughout a long culture period such as iPSC differentiation into a 
specialized cell or tissue type, which usually takes a month. Usually, it 
requires multiple weeks for iPSCs to differentiate into functional insulin 
secreting beta cells. Simply increasing collagen concentration alters 
mechanical property of the gel and may negatively affect iPSC proliferation 
and differentiation (Weinberg and Bell, 1983). One possible solution is to 
develop scaffolds by blending another polymer fiber, such as poly(ethylene 
glycol) diacrylate (PEGDA), into the original collagen fibers. 
 
Collagen-PEGDA interpenetrating network 
 PEGDA is a popular polymer applied in tissue engineering recently. 
Munoz-Pinto et al. reported a PEGDA-collagen interpenetrating network 
(IPN) for vascular tissue engineering. They first formed a collagen hydrogel, 
infiltrated with PEGDA solution, and subsequently crosslinked the PEGDA 
by exposing to longwave UV light. The collagen-PEGDA IPN showed not 
only improvement of mechanical stiffness, but also better thromboresistance 
and resistance to contraction. They used human mesenchymal stem cells 
(MSCs) to evaluate cell viability, the result showed a 90% survival rate after 
the cell encapsulation and fabrication process. They claimed that collagen-
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PEGDA IPN can support the initial stages of smooth muscle cell lineage 
progression by elongated human mesenchymal stems cells (Munoz-Pinto et. 
al., 2014).  
  
Objectives of the study 
 The goal of this study is to develop a collagen-PEGDA hydrogel scaffold 
for iPSC lineage specification. Studies in our laboratory suggested that 3D 
scaffolds developed for culture and differentiation of MSCs may not 
applicable to iPSCs, due to unique cell-cell and cell-ECM interactions 
required for iPSCs to survive, proliferate, and differentiate. To date, 
development of scaffold gels that support direct seeding and differentiation 
of human iPSCs remains challenging. We hypothesized that a collagen-
PEGDA IPN may not only increase scaffold’s stiffness and stability, but also 
allow for direct seeding and differentiation of iPSCs. The scaffold should 
show enough stiffness and a significant improvement of shrinkage resistance 
throughout a four-week culture process compared to a no-PEGDA/UV 
treated collagen hydrogel scaffold. The collagen-PEGDA IPN scaffold 
should also support iPSCs’ proliferation and spontaneous differentiation. 
Thus, in this study, we developed collagen-based scaffolds. We assessed the 
stability of the scaffolds, cell viability, and spontaneous differentiation 
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capacity of iPSCs seeded in the scaffolds. The research work helps build a 
panel of scaffolds that are potential for artificial pancreatic development in 
the future. The ultimate goal is to develop proper collagen-based 3D 
scaffolds for human iPSCs differentiation into functioning pancreatic cells. 
 
  
10  
  
 
Chapter 2. Materials and Methods 
IMR90 cells culture 
In this project, the iPSC line, IMR90, was purchased from WiCell. 
Maintenance and culture of IMR90 involved using mTeSR1 medium, a 
proprietary cell culture medium developed for stem cell culture. To prepare 
complete mTeSR1 medium, mTeSR1 basal medium (StemCell Technologies) 
and mTeSR1 5X supplement (StemCell Technologies) were thawed at 4°C 
overnight. Mix 100mL of mTeSR1 5X supplement with 400 mL of mTeSR1 
basal medium together to prepare 500 mL mTeSR1 medium, then keep the 
mixture under 4°C for further use. After passaging, IMR90 cells were cultured 
in mTeSR1 medium under 37°C, 5% CO2 atmosphere for 3 to 4 days, before 
colonies were big enough to touch nearby colonies. The medium should be 
changed daily to provide enough nutrients and anti-differentiation signaling 
molecules. 
 
IMR90 cells passaging 
When two IMR90 colonies get close enough, they may exchange signaling 
factors and are more likely to differentiate and lose pluripotency. To avoid 
such problem, IMR90 cells requires passaging every 3 to 4 days, depending 
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on the cell density. In this project, an enzyme-based passaging protocol 
provided by StemCell Technologies was followed. Passaging protocol is 
introduced briefly below: First, coat the vessel with 1:100 diluted Matrigel 
(Corning) solution in DMEM/F12 (Hyclone) for 60 minutes before the 
passaging. Then take out the cells to be passaged, remove the unhealthy 
colonies, and incubate with Dispase (1 U/mL, StemCell Technologies) at 37°C 
for 6 minutes. After the incubation, aspirate Dispase and rinse the cells with 
DMEM/F12 medium twice. After that, add mTeSR1 medium and gently 
scrape off the colonies, transfer the detached cells to a 15mL centrifuge tube. 
Break up the cell colonies into proper size by gentle pipetting, and then 
transfer the cells to the pre-coated vessels for further culture. 
 
Seeding IMR90 cells into 3D collagen gel scaffold 
After reaching proper density, cells can be harvested for seeding. To 
prepare a collagen hydrogel seeded with single IMR90 cells, the following 
ingredients were required: Type I collagen (from rat tail, 10.25 mg/mL, 
Corning), 10x DMEM medium (Thermo Scientific), cell culture grade water 
(Thermo Scientific), NaOH solution for pH adjustment, and cell suspension. 
To prepare the cell suspension, incubate the cell colonies in mTeSR1 
medium containing Rock Inhibitor (5 μM, StemCell technologies) at 37°C, 5% 
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CO2 atmosphere for 2 hours. Then remove medium and add 2 mL Accutase 
(for a 100 mm dish) into the petri dish. Incubate at 37°C for 7 minutes to digest 
the colonies, then add 10 mL DMEM/F12 medium (5 times the volume of 
Accutase) to cease the reaction. Transfer the cell suspension into a centrifuge 
tube and centrifuge at 200 rcf for 5 minutes. After centrifugation, remove the 
supernatant and resuspend the cell pellet again with mTeSR1 medium to make 
cell suspension. The volume of mTeSR1 medium depends on the cell density 
required in the final hydrogel.  
In this project, a final concentration of 2.5 mg/mL for collagen I was used. 
In the beginning of the project, final cell density was set to 2 million cells per 
microliter, however this number was adjusted and increased to 4 to 5 million 
cells per microliter in further experiments to improve cell viability. To prepare 
the hydrogel, collagen I, 10x DMEM medium, and cell culture grade water 
were mixed properly, and pH was adjusted to 7.4 using 1 M NaOH. After the 
pH was neutralized, add in cell suspension, and mix gently and thoroughly. 
This whole procedure of preparing the hydrogel was carried out on ice to 
prevent gelation.  
After cell suspension was properly mixed with collagen, transfer the 
hydrogel into a 24-well plate (Costar, Corning Inc.). In this project, 
hydrogels were made 2 mm thick, so the volume of hydrogel solution in 
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each well of 24 well plate was 380 micro liters. The physical crosslinking of 
collagen hydrogel requires incubation at 37°C for at least 30 minutes. After 
the gelation, add 600 microliters of mTeSR1 medium with Rock Inhibitor to 
each well and culture the cells at 37C CO2 incubator for 24 hours. 
 
Prepare of PEGDA precursor solution and photocrosslinking of PEGDA 
To make the inter-penetrating network, PEGDA fibers are fabricated into 
the collagen hydrogel. This procedure includes two parts: infiltration of the 
PEGDA precursor solution into the collagen gel and photocrosslinking under 
UV light. 
In this project, PEGDA was purchased from Sigma Aldrich with average 
molecular weight of 2000 Da. Two different types of photocrosslinking 
initiators (photoinitiator, PI) were selected in this project: 2-Hydroxy-4’-(2-
hydroxyethoxy)-2-methylpropiophenone (Irgacure D-2959, I2959, Aldrich) 
and lithium phenyl-2,4,6-trimethylbenzoylphosphinate (LAP, Aldrich). 
I2959 has been reported to be used in tissue engineering by multiple articles 
(Montgomery et al., 2017, Ahadian et al., 2016, Assal et al., 2016). LAP is 
another PI with greater solubility in water, and it is functional under both 
UV and visible light (Singh et al., 2015, Fairbanks et al., 2009). In this 
project, a UVL-56 Handheld UV Lamp (6 Watt, 365nm) was used as the 
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light source for photopolymerization.  
To prepare the PEGDA precursor solution, PI and PEGDA powder are 
dissolved in mTeSR1 medium. According to the results of the pre-
experiments, the concentration of I2959 in this project was 0.03% w/v and 
LAP concentration was 0.25% w/v. The PEGDA concentration is set to 7%, 
5%, 3%, 1%, and 0%. Collagen hydrogel with the same collagen I 
concentration but without PEGDA treatment was used as a control. 
After the hydrogel has rested for twenty-four hours, remove the medium in 
each well, and add 190 micro liters of precursor solution in relevant well, 
then let infiltrate for 45 minutes. After that, replace the precursor solution 
with 600 microliters of fresh mTeSR1 medium containing Rock Inhibitor. 
Put the plate under the UV lamp for photopolymerization for 6 minutes 
(I2959 as PI) or 2 minutes (LAP as PI). During the photopolymerization, 
PEGDA fibers would penetrated into the hydrogel. Schematic representation 
of the sequential collagen-PEGDA hydrogel fabricating process is showed 
below in figure 4. 
After the photocrosslinking, put the plate back into the incubator for 24 
hours at 37°C, 5% CO2 atmosphere. 
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Figure 1. Schematic representation of the sequential Collagen-PEGDA hydrogel fabricating process. 
 
 
Spontaneous differentiation of IMR90 in the hydrogel 
To let IMR90 cells differentiate spontaneously, culture medium is 
switched from mTeSR1 to IMDM (Gibco) with 10% embryonic stem (ES) 
cell fetal bovine serum (FBS, Gibco) 24 hours after the photocrosslinking is 
finished. The new IMDM/10%FBS medium is changed every other day. 
Rock inhibitor (10 μM) is added to the medium for the first two days in 
order to improve cell viability. Photos of cell morphology is taken on day 1 
(one day after spontaneous differentiation initiates), day 4, and day 7. The 
differentiation period is set to 7 days, after which the collagen hydrogel 
scaffold is used for either live & dead staining to evaluate cell viability, or 
RNA extraction to get total RNA for evaluation of marker gene expression. 
Photos were analyzed using NIS-Elements Analysis Software (Version 3.2). 
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RNA extraction and quantitative real-time polymerase chain reaction 
analysis 
After 7 days of differentiation, the scaffolds were harvested for RNA 
extraction. Total RNA samples were extracted using RNeasy plus mini kit 
(QIAGEN). To evaluate how IMR90 cells spontaneously differentiate into 
endoderm, mesoderm, and ectoderm, collected RNA samples were analyzed 
by quantitative qRT-PCR. Six genes were examined: Sox17 and Foxa2 
(markers of endoderm cells), Hand1 and ABCG2 (markers of mesoderm 
cells), and Nestin and CD44 (markers of ectoderm cells). Cyclophilin is used 
as a housekeeping gene. In this project, QuantiTect Multiplex RT-PCR NR 
Kit (QIAGEN) is used.  
 
Stability test for the collagen-PEGDA hydrogel scaffold 
Hydrogel solution was transferred into 96 well plate (Corning) to make 
1.5 mm-thick gel. After treated with relevant PEGDA precursor solution and 
photocrosslinked, hydrogels were cultured in IMDM containing 10%FBS for 
28 days. Images of the gels were taken on day 7 (week 1), day 14 (week 2), 
day 21 (week 3), and day 28 (week 4). Since the measurement of thickness 
is not feasible after weeks of culture, in stability test gel thickness was set to 
1.5 mm and the change of surface area of each group was recorded. 
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Chapter 3. Results 
Optimization of LAP concentration in precursor solution 
 According to previous studies in the laboratory, pure PEGDA molecule 
with a molecular weight of 2000 Da didn’t show toxic effect on IMR90 
cells. A validation of photoinitiator concentration was required to reach the 
optimal photocrosslinking and culture condition. 
To test the tolerance of IMR90 cells to photoinitiator LAP molecule, 
IMR90 cells were seeded in collagen hydrogel and treated with different 
concentrations of LAP. No PEGDA were used to avoid PEGDA’s effect on 
cell proliferation and differentiation. The concentrations of LAP were set to 
0.5% w/v, 0.25% w/v, 0.1% w/v, and 0.05% w/v. A group with no LAP was 
used as control.  
The differentiation process lasted for 7 days. Live & dead staining was 
carried out on day 1 and day 7 to examine cell viability. The result was 
shown as below: 
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Figure 2. Live & dead staining of IMR90 cell spontaneous differentiation with different LAP 
concentrations, day 1 and day 7. Magnification: 200 (day 1 results) and 100 (day 7 results), scale bar: 100 
microns (day 1 results) and 50 microns (day 7 results). (a) 0.05% w/v and 0.1% w/v. (b) 0.25 % w/v and 
0.5% w/v of LAP. 
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 According to the results, cell can survive when treated with 0.25% w/v 
LAP. To improve the photocrosslinking efficiency, a higher dose of catalyst 
was preferred. Therefore, 0.25% w/v was decided to be the LAP 
concentration in the precursor solution for further experiments. 
 Also, the staining result indicated that throughout the spontaneous 
differentiation, cell aggregates showed better viability. Most of the single 
cells was dead after 7 days of proliferation and differentiation. 
 
Optimization of I2959 concentration in precursor solution 
 I2959 was another type of photoinitiator used in this project. Similarly, 
to find the optimal I2959 concentration, concentrations of 0.01% w/v, 0.03% 
w/v, 0.1% w/v, and 0.3% w/v were tested. The UV irradiation time was set 
to 6 minutes. A I2959/UV un-treated group was used as a control. Photos of 
cell morphologies were taken on day 1, 4, and 7. The results were shown as 
below. 
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Figure 3. Cell morphologies of IMR90 cell spontaneous differentiation with different precursor solution 
I2959 concentrations, at day 1, 4, and 7. Magnification: 200. Scale bar: 50 microns. (a) Control group and 
0.01% w/v. (b) 0.03 % w/v and 0.1% w/v. (c) 0.3% w/v of I2959. 
 According the results, 0.01% w/v and 0.03% w/v groups produced large 
and dense sphere-like cell aggregates (showed in green in live/dead staining 
image) which are similar to those in I2959/UV un-treated control group. In 
0.1% w/v and 0.3% w/v groups, most cells are dead. The results indicated 
that IMR90 cell can tolerate at least 0.03% w/v of I2959. This may allow 
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reaching to a higher photo-polymerization efficiency. Thus, I2959 
concentration in precursor solution was set to 0.03% w/v. 
 
UV irradiation duration affects cell viability 
 Our experimental results indicated that the optimal I2959 concentration 
was 10 times less than the concentration reported by a literature, where0.3% 
w/v of I2959 was used for MSCs. (Munoz-Pinto et. al., 2014). In addition, 
our optimal LAP concentration was half of reported concentration for mouse 
3T3 fibroblast, where 0.5% w/v of LAP was used.  (Xu et al., 2018). These 
comparisons again indicated that human iPSCs require unique 
microenvironments for cell survival and proliferation as mentioned earlier. It 
may also due to different tolerance to PIs of different cell lines. 
Another factor that affects cell viability can be UV irradiation dose, since 
energy accumulation of UV may reduce cell viability. An experiment was 
done to validate this assumption.  
 In this experiment, cells were seeded into the collagen hydrogel (2.5 
mg/mL collagen concentration) with the same cell density. I2959 was chosen 
as the photoinitiator. The concentration of I2959 was set to 0.3% w/v. The 
UV irradiation time tested were 6 minutes, 2 minutes and 0 minutes (0 min 
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as control). Cell morphologies and viability were monitored throughout a 4-
day differentiation process. The images are shown below: 
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Figure 4. Cell morphologies of IMR90 cell (treated with 0.3% w/v I2959 as photoinitiator) spontaneous 
differentiation with different UV irradiation time, at day 1 and day 4. Magnification: 40 (left panel 
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 in each row), 200 (right panel in each row). Scale bar: 100 micrometers. (a) Control group, no UV 
irradiation. (b) 2 minutes UV irradiation. (c) 6 minutes UV irradiation. 
 The result of 6 minutes UV irradiation group was consistent to previous 
result, the cell viability was low. However, the 2 minutes UV irradiation 
group and control group showed dense sphere-like cell aggregates after 4 
days of spontaneous differentiation. However, 2 min of UV treatment might 
be inadequate for an efficient photocrosslinking. 
Optimization of PEGDA concentration in the precursor solution 
 After the optimal photoinitiator concentrations were decided, further 
experiments were carried out to find optimal PEGDA concentration for a 
collagen-PEGDA IPN scaffold.  
Optimization of PEGDA concentration in PEGDA/LAP precursor 
solution 
 To find the optimal PEGDA concentration in the precursor solution, LAP 
concentration was set to 0.25% w/v and UV irradiation time is set to 2 
minutes. Cell seeding and photocrosslinking protocols were the same as 
mentioned in the Method part. PEGDA concentrations were set to 1% w/v, 
3% w/v, 5% w/v, and 7% w/v. A PEGDA/UV un-treated group was set as a 
control. Cell status and morphologies were monitored throughout the 7-day 
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spontaneous differentiation process. After 7 days of differentiation, RNA 
was extracted from each group for further qRT-PCR analysis. 
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Figure 5. Cell morphologies of IMR90 cell (treated with 0.25% w/v LAP as photoinitiator, 2 minutes of UV 
irradiation) spontaneous differentiation with different PEGDA concentrations, at day 1, 4, and 7. 
Magnification: 200. Scale bar: 50 microns (a) and 100 microns (b and c). (a) Control group (no 
PEGDA/UV treatment) and 1% w/v PEGDA group. (b) 3% w/v PEGDA group and 5% w/v PEGDA group 
(c) 7% PEGDA group. 
 Large quantity of sphere-shape or plate-shape cell aggregates were found 
in 1% w/v PEGDA group after 7 days (Figure 5a), and enough RNA sample 
for further gene expression analysis was extracted from this group. In 3% 
w/v group, cell aggregates appeared in the first 4 days, but on day 7 few 
aggregates could be visualized, and the amount of extracted RNA was not 
enough for qRT-PCR analysis. For the 5% w/v and 7% w/v PEGDA groups, 
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much smaller aggregates were formed in the first 4 days, which eventually 
vanished on day 7 of differentiation (Figure 5b and c), leading to inadequate 
amount of RNA sample extracted. 
 Amount of RNA sample extracted from the cells and cell morphologies 
represented the cell viability after 7 days of differentiation. According to the 
results, a 1% w/v PEGDA + 0.25% w/v LAP/2 minutes UV irradiation 
treatment was a feasible photocrosslinking condition for iPSCs. 
Optimization of PEGDA concentration in PEGDA/I2959 precursor 
solution 
To find the optimal PEGDA concentration in the precursor solution, 
I2959 concentration was set to 0.03% w/v and UV irradiation time was set to 
6 minutes. Cell seeding and photocrosslinking protocols were the same as 
mentioned in method part. PEGDA concentrations tested were 1% w/v, 3% 
w/v, 5% w/v, and 7% w/v. A PEGDA/UV un-treated group was used as a 
control. Cell status and morphologies were monitored throughout the 7-day 
spontaneous differentiation process. After 7 days of differentiation, RNA 
samples were extracted from each group for further qRT-PCR analysis. 
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Figure 6. Cell morphologies of IMR90 cell (treated with 0.03% w/v I2959 as photoinitiator, 6 minutes of 
UV irradiation) spontaneous differentiation with different PEGDA concentrations, at day 1, 4, and 7. 
Magnification: 200. Scale bar: 100 microns. (a) Control group (no PEGDA/UV treatment) and 1% w/v 
PEGDA group. (b) 3% w/v PEGDA group and 5% w/v PEGDA group. (c) 7% PEGDA group. 
Large quantity of sphere-shape or plate-shape cell aggregates were found 
in 1% w/v and 3% PEGDA group after 7 days (Figure 6a and b), and enough 
RNA sample for further gene expression analysis was extracted from these 
two groups. In 5% w/v group, not many large cell aggregates could be found 
in the hydrogel (Figure 6b), and RNA extracted was not enough for qRT-
PCR analysis. For the 7% w/v group, cells failed to form aggregates 
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throughout the differentiation process (Figure 6c). Most cells were dead 
after 7 days of IMDM/10% FBS treatment. 
Amount of RNA sample extracted from the cells and the cell 
morphologies represent the cell viability after 7 days of differentiation. 
According to results above, two treatments: 1% w/v PEGDA + 0.03% w/v 
I2959/6 minutes UV irradiation, and 3% w/v PEGDA + 0.03% w/v I2959/6 
minutes UV irradiation, were considered to be optimal photocrosslinking 
conditions for this project. 
 
Assessment of the stability of collagen/PEGDA IPN scaffolds 
 The main propose of fabricating PEGDA fibers into collagen fibers is to 
improve the shrinkage resistance of the scaffold, allowing the scaffold to 
withstand up to several weeks during differentiation process. As described 
above, we identified three formulas that are feasible to proliferate and 
differentiate. They are: (1) 1% w/v PEGDA + 0.25% w/v LAP/2 minutes 
UV irradiation; (2) 1% w/v PEGDA + 0.03% w/v I2959/6 minutes UV 
irradiation; and (3) 3% w/v PEGDA + 0.03% w/v I2959/6 minutes UV 
irradiation. This stability test aims to evaluate the abilities of formulas 
mentioned above against scaffold shrinkage. 
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 Briefly, gelation was conducted in a 96-well plate instead of 24-well 
plates, followed by same treatment mentioned previously. Cell density was 
approximately 4.5 million cells per mL and they were cultured in IMDM 
culture medium containing 10% FBS for 4 weeks. The gel was made 1.5 
mm thick to minimize thickness change, which is not feasible to measure. 
None PEGDA/UV treatment group was used as a control. Images of each 
group were taken post seeding 1-, 2-, 3- and 4-week. The surface area of 
scaffolds was measured using the NIS analysis software. Data were 
collected from two independent experiments. Quantitative data are shown 
below: 
 
Figure 7. Surface area change of each group on week 1, 2, 3 and 4.  *: p<0.05, **: p<0.01, ns: no 
significance. 
The results showed a significant difference of gel surface area between 
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pure collagen control and three scaffolds after 4 weeks of culture. This 
indicated all the three formulas can significantly improve the shrinkage 
resistance of the scaffolds. There is a significant improvement of shrinkage 
resistance between 1% PEGDA +0.25% LAP/2 min UV and 3% PEGDA + 
0.03% I2959/6 min UV. No significance was found in other two 
comparisons 
 
Assessment of the pluripotency of the cells cultured in the scaffolds  
 To assess whether iPSCs cultured in the 3D scaffolds still maintain 
pluripotency, the cells were cultured in spontaneous differentiation medium 
for a week to allow the initiation of the development of three germ layers 
from iPSCs. The differentiation status of each group was evaluated by qRT-
PCR to measure marker gene expression. Sox17, Foxa2, Hand1, ABCG2, 
Nestin, and CD44 were chosen as expression markers for endoderm, 
mesoderm, and ectoderm, respectively. Cyclophilin was chosen as the 
housekeeping gene. Undifferentiated IMR90 cultured in 2D (4 days, in 
mTeSR1) for 4 days and IMR90 cultured in pure collagen hydrogel (7 days, 
in IMDM + 10% FBS) were used as control. The experiments were repeated 
three times and RNA samples from three independent experiments were 
subjected to the analysis. 
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Figure 8. Gene expression analysis of RNA samples extracted from the collagen-PEGDA scaffolds. RNA 
extracted from undifferentiated IMR90 was applied as a control for normalization. Three independent 
experiments were carried out. Y axis is fold change. (a) Relative expression of Sox17, Foxa2, ABCG2, 
Nestin, and CD44 in the three types of scaffolds and pure collagen scaffold. (b) Relative expression of 
Hand1 in the three types of scaffolds and pure collagen scaffold. Asterisks represent significant level of 
relative expression difference compared with undifferentiated cells, *: p<0.05, **: p<0.01, ns: no 
significance. 
 Figure 8 indicated that iPSCs seeded in all three types of scaffolds 
differentiated spontaneously and preferentially towards mesoderm, as 
marked by extremely high Hand1 expression after one week of culture 
(Figure 8b). There was a certain degree of ectoderm progression as shown in 
Figure 8a with Nestin and CD44. Endoderm differentiation that measured by 
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Sox17 and Foxa2 was not supported by the three types of gels tested. The 
expression level of ABCG2 and Nestin in the three scaffolds is higher 
compared to undifferentiated IMR90 but lower than cell seeded in pure 
collagen hydrogel. 
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Chapter 4. Discussion and Conclusion 
 The elastic modulus of collagen hydrogel ranges from 1 to 100 Pa (Yang, 
Kaufman, 2009). Also, as mentioned before, increasing collagen 
concentration does not significantly change the stiffness (Weinberg, 1986). 
The collagen hydrogel scaffolds provide a soft and porous environment to 
cells to elongate and cluster. During the iPSC biocompatibility assessment of 
this study, the control group with no PEGDA/UV treatment showed the 
highest cell viability. Cells in control group clustered and formed larger 
sphere-shaped and plate-shaped aggregates, and the nutrients were 
exhausted more quickly than other experimental groups. 
 During the development of scaffolds for iPSC culture and differentiation, 
several factors showed ability to affect cell viability. The first factor is cell 
seeding density. In the beginning of this project, cell seeding density is set to 
2.5 million cells per mL of hydrogel to remain consistent to former project 
of the laboratory. This seeding density is raised to 4.5 million cells per mL 
eventually to reach better cell viability and spontaneous differentiation. 
Talukdar et. al. reported that an increase of initial seeding density of 
chondrocytes in a 3D silk fibroin scaffold can significantly increase total wet 
weight after 2 weeks of culture. Seeding iPSCs at a higher density may 
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enhance cell-cell interaction and thus improve cell proliferation and 
differentiation. 
 The second factor is the toxicity of precursor solution, which in this 
project is the toxicity of the photoinitiators. Our experimental results 
revealed that when treat cells with UV irradiation, experimental groups 
treated with higher concentration of photoinitiator showed lower cell 
viability after the 7 days differentiation process. iPSCs’ tolerance to PIs are 
lower than other types of stem cells such as MSCs. However, PIs act as the 
catalyst in the PEGDA photocrosslinking reaction. Thus, a low PI 
concentration may affect the photocrosslinking efficiency, influencing the 
stiffnesses of the scaffolds. 
 UV irradiation is another factor. Figure 4 revealed that when treat cells 
with precursor solution with the same I2959 concentration, a longer UV 
irradiation time leads to a decrease of cell viability. Compared to I2959, 
LAP requires 2 minutes of UV irradiation instead of 6 minutes. The mock 
control (no PEGDA, only PIs and UV) results of LAP showed better cell 
viability than I2959 at same concentrations.  
LAP can also catalyze PEGDA photocrosslinking under visible light 
(400 nm), thus avoid the harmful effect of UV. Also, the improved 
polymerization kinetics enable cell encapsulation at reduced initiator 
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concentration, which has been shown to reduce initiator toxicity and 
increase cell viability. This is consistent to the stability test results that LAP 
treated scaffold showed greater stability at the same PEGDA concentration. 
In general, LAP, the PI with a shorter UV irradiation time and a higher 
catalysis efficiency, is superior to I2959 in this project. Compared to UV, 
visible lights are more biocompatible to stem cells. Eosin Y photosensitizer 
is another type of PI that can initiate photo polymerization of PEGDA under 
visible light (Bahney et al., 2011, Wang et al., 2015). 
In addition, 1% PEGDA + 0.25% LAP + 2 minutes UV group showed 
greater shrinkage resistance than the other I2959 treated groups, but the 
amount of RNA extracted (around 3000 ng per well) is less than I2959 
treated groups (6000 to 8400 ng per well). These data imply that I2959-
treated collagen gels are more biocompatible to iPSCs, and perhaps they are 
softer than LAP-treated gel. The softness of I2959 groups may result from 
the lack of photocrosslinking efficiency of I2959 at 365 nm. Also, when 
optimize the PEGDA concentration in LAP groups, 3%, 5% and 7% PEGDA 
groups showed low cell survival rate. This may imply that when increasing 
the PEGDA concentration in PEGDA/LAP precursor solutions, more 
PEGDA fibers are polymerized and fabricated into the collagen hydrogel, 
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thus increase the stiffness of the scaffold, and limit the cluster formation and 
aggregation of cells, and ultimately hinder the cell viability. 
For the pluripotency assessment, the gene expression level of ABCG2, 
Nestin, and CD44 are not particularly higher than control. This may due to 
the lack of differentiation time, since cells may only differentiate into an 
early stage of certain germ layers. Another drawback of this study is that the 
stability assessment was done twice instead of three times due to insufficient 
time, making the result not as reliable.  
In further research, mechanical properties such as elastic modulus may 
be measured to evaluate the effect of mechanical properties of these 
collagen-PEGDA scaffolds on iPSC cultures. In human body, different 
tissues have different stiffnesses. Take pancreas tissue as an example, the 
overall mean shear stiffness of pancreas is 1150±170 Pa at 40Hz and 
2090±330 Pa at 60 Hz (Shi, et.al, 2015). This project built a panel for 
PEGDA-collagen hydrogel scaffold for tissue engineering. The stiffness of 
the collagen-PEGDA hydrogel scaffolds can be adjusted to proper level to 
support pancreas tissue engineering by altering several parameters, such as 
PEGDA molecular weight and PEGDA concentration. In addition, iPSC 
differentiation capacity in the scaffolds should be assessed by culture cells 
for a few weeks to allow fully lineage progression. 
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As for conclusion, this project aimed to develop a collagen-PEGDA 
hydrogel scaffold that can support direct seeding and differentiation of 
iPSCs. By optimizing multiple factors, including photoinitiator type, 
photoinitiator concentration, PEGDA concentration, and UV irradiation, 
three formulas (1) 1% w/v PEGDA + 0.25% w/v LAP/2 minutes UV 
irradiation, (2) 1% w/v PEGDA + 0.03% w/v I2959/6 minutes UV 
irradiation, and (3) 3% w/v PEGDA + 0.03% w/v I2959/6 minutes UV 
irradiation were developed. qRT-PCR results revealed that the scaffolds 
could support IMR90 cells to spontaneously differentiate into mesoderm. 
The stability test results showed significant improvement of shrinkage 
resistance of the formulas compared to collagen hydrogel. This work 
provides a method for developing 3D collagen scaffolds that can support 
iPSC seeding, proliferation, and differentiation in long-term 3D culture.  
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